Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?

BMC Medical Research Methodology

Volumn 14, Issue 1, 2014, Pages

  Takeshima, Nozomi ^a   Sozu, Takashi ^a   Tajika, Aran ^a   Ogawa, Yusuke ^a   Hayasaka, Yu ^a   Furukawa, Toshiaki A ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; HUMAN; OUTCOME ASSESSMENT; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; STATISTICS;

DATA INTERPRETATION, STATISTICAL; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84897602753     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-14-30     Document Type: Article

References (25)

1. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011, Higgins JPT, Green S, Available from http://www.cochrane-handbook.org
2. Cohen J, Statistical Power Analysis for the Behavioral Sciences Hillsdale, New Jersey: Lawrence Erlbaum Associates: Routledge 1988
3. Primary, secondary, and meta-analysis of research. Glass GV, Educ Res 1976 5 10 3 8
4. Hedges LV, Olkin I, Statistiker M, Olkin I, Olkin I, Statistical Methods for Meta-Analysis New York: Academic Press 1985
5. Statistical methods in psychology journals: guidelines and explanations. Wilkinson L, Am Psychol 1999 54 8 594
6. Egger M, Smith GD, Altman D, Systematic Reviews in Health Care: Meta-Analysis in Context 2008 Wiley. com
7. Association AP, Publication Manual of the American Psychological Association Washington, DC: American Psychological Association 6 2009
8. Borenstein M, Hedges LV, Higgins JP, Rothstein HR, Introduction to Meta-Analysis 2011 Wiley. com
9. Inferences on standardized mean difference: the generalized variable approach. Tian L, Stat Med 2007 26 5 945 953 10.1002/sim.2589 16708348
10. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Furukawa TA, Guyatt GH, Griffith LE, Int J Epidemiol 2002 31 1 72 76 10.1093/ije/31.1.72 11914297
11. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. Jørgensen AW, Hilden J, Gøtzsche PC, BMJ 2006 333 7572 782 10.1136/bmj.38973.444699.0B 17028106
12. Methodology and reports of systematic reviews and meta-analyses. Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M, Moher D, JAMA 1998 280 3 278 280 10.1001/jama.280.3.278 9676681
13. Measuring inconsistency in meta-analyses. Higgins JP, Thompson SG, Deeks JJ, Altman DG, BMJ 2003 327 7414 557 10.1136/bmj.327.7414.557 12958120
14. Meta-analysis in clinical trials. DerSimonian R, Laird N, Control Clin Trials 1986 7 3 177 188 10.1016/0197-2456(86)90046-2 3802833
15. Methods for combining randomized clinical trials: strengths and limitations. DeMets DL, Stat Med 1987 6 3 341 348 10.1002/sim.4780060325 3616287
16. Cooper H, Hedges LV, Valentine JC, Handbook of Research Synthesis and Meta-Analysis New York: Russell Sage Foundation 2009
17. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. Friedrich JO, Adhikari NK, Beyene J, J Clin Epidemiol 2011 64 5 556 564 10.1016/j.jclinepi.2010.09.016 21447428
18. Ratio of geometric means to analyze continuous outcomes in meta-analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation. Friedrich JO, Adhikari NK, Beyene J, Stat Med 2012 31 17 1857 1886 10.1002/sim.4501 22438170
19. A rating scale for depression. Hamilton M, J Neurol Neurosurg Psychiatry 1960 23 56 62 10.1136/jnnp.23.1.56 14399272
20. Ware JE, Snow KK, Kosinski M, SF-36 Health Survey: Manual and Interpretation Guide London, RI: Quality Metric Incorporated 1993
21. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Kunz B, Oranje A, Labreze L, Stalder J-F, Ring J, Taieb A, Dermatology 1997 195 1 10 19
22. From effect size into number needed to treat. Furukawa TA, Lancet 1999 353 9165 1680
23. Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study. da Costa BR, Rutjes AW, Johnston BC, Reichenbach S, Nüesch E, Tonia T, Gemperli A, Guyatt GH, Jüni P, Int J Epidemiol 2012 41 5 1445 1459 10.1093/ije/dys124 23045205
24. GRADE guidelines: 13 Preparing summary of findings tables and evidence profiles-continuous outcomes. Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, Johnston BC, Karanicolas P, Akl EA, Vist G, et al. J Clin Epidemiol 2013 66 2 173 183 10.1016/j.jclinepi.2012.08.001 23116689
25. Pooling healthrelated quality of life outcomes in metaanalysis-a tutorial and review of methods for enhancing interpretability. Thorlund K, Walter SD, Johnston BC, Furukawa TA, Guyatt GH, Res Synth Methods 2011 2 3 188 203 10.1002/jrsm.46